Fowl Cholera in Chickens: Etiology, Clinical Signs, Diagnosis, and Control

Introduction

Fowl cholera, also termed avian pasteurellosis, is a highly contagious septicemic disease of domestic and wild birds caused by the gram-negative coccobacillus Pasteurella multocida [1]. The disease constitutes one of the most economically significant bacterial threats to commercial poultry operations globally, particularly affecting layer and breeder flocks [2]. Fowl cholera in chickens occurs in peracute, acute, and chronic forms, with clinical expression governed by bacterial strain virulence, host immune competence, and environmental stressors [3]. This reference article presents a comprehensive examination of the etiology, epidemiology, clinical presentation, pathological mechanisms, diagnostic methodology, therapeutic approaches, and control strategies for fowl cholera in chickens, with emphasis on the molecular and biophysical basis of pathogenesis.

Etiology

Characteristics of Pasteurella multocida

Pasteurella multocida is a nonmotile, non-spore-forming, facultatively anaerobic, gram-negative coccobacillus classified within the family Pasteurellaceae [1]. Individual cells measure approximately 0.2 to 0.4 micrometers in width and 0.6 to 2.5 micrometers in length and exhibit characteristic bipolar staining when treated with methylene blue or Wright stain [2]. The bacterial cell envelope comprises an inner cytoplasmic membrane, a thin peptidoglycan layer, and an outer membrane containing lipopolysaccharide (LPS) and capsular polysaccharide, both of which are essential virulence determinants [3].

Five capsular serogroups (A, B, D, E, F) and 16 somatic LPS serotypes (1 through 16) have been defined by the Carter-Heddleston classification system [1]. In avian isolates, capsular serogroups A and D predominate, with somatic serotypes 1, 3, and 4 most frequently incriminated in fowl cholera outbreaks among chickens [2]. The virulence arsenal of P. multocida includes capsular polysaccharides, LPS, outer membrane proteins (OmpA, OmpH, Oma87), fimbriae, and the 146 kilodalton dermonecrotoxin (PMT) elaborated predominantly by serogroup D strains [3].

Virulence Factors and Pathogenesis

The capsular polysaccharide of serogroup A strains is composed principally of hyaluronic acid, which inhibits phagocytosis by avian macrophages and heterophils through steric hindrance and interference with Fc receptor binding [1]. Lipopolysaccharide molecules activate the avian Toll-like receptor 4 (TLR4) signaling cascade, triggering release of proinflammatory cytokines including interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha), which induce fever, vascular endothelial damage, and disseminated intravascular coagulation [2]. Outer membrane proteins OmpA and OmpH facilitate bacterial adhesion to host epithelial cells and extracellular matrix components such as fibronectin and laminin [3].

Fimbrial structures mediate initial attachment to the respiratory mucosal epithelium, the primary portal of entry [1]. Following adherence, the bacterium breaches the mucosal barrier through paracellular translocation and enters the bloodstream, achieving septicemic dissemination within 12 to 24 hours in susceptible chickens [2]. The dermonecrotoxin PMT activates intracellular Rho GTPase signaling pathways, causing cytoskeletal rearrangement, disruption of tight junctions, and increased paracellular permeability that facilitates systemic invasion [3].

Epidemiology

Host Range and Transmission

Fowl cholera affects a broad range of avian species; chickens, turkeys, ducks, and geese are particularly susceptible [1]. Chickens exhibit lower inherent susceptibility compared with turkeys, with morbidity and mortality rates ranging from 20 percent to 80 percent depending on flock immunity, bacterial strain virulence, and management conditions [2]. Wild waterfowl, especially mallards and Canada geese, serve as reservoir hosts and introduce P. multocida into domestic poultry operations through contaminated water sources or direct bird-to-bird contact at the interface of wild and domestic habitats [3].

Transmission occurs predominantly through horizontal routes: inhalation of aerosolized bacteria, ingestion of contaminated feed or water, and direct contact with infected birds, fomites, or contaminated equipment [1]. The bacterium survives for up to 30 days in moist organic substrates including soil, litter, and decomposing carcasses under optimal temperature and humidity conditions [2]. Chronically infected carrier birds, particularly those harboring localized infections of the wattles, infraorbital sinuses, or synovial structures, constitute a persistent within-flock source of infection [3].

Risk Factors

Environmental and management factors that increase flock susceptibility to fowl cholera in chickens include high stocking density, inadequate ventilation, nutritional imbalances (especially vitamin A and selenium deficiencies), concurrent immunosuppressive infections (e.g., infectious bursal disease virus, chicken anemia virus), and physiological stress [1]. Stressors such as extreme ambient temperatures, transport, handling, and onset of egg production can precipitate clinical outbreaks in laterally infected flocks by elevating endogenous corticosteroid levels and suppressing cell-mediated immunity [2]. Biosecurity deficiencies, including shared water sources, contaminated egg flats and transport crates, and introduction of replacement birds without adequate quarantine, facilitate pathogen entry and between-flock transmission [3].

Clinical Signs

Peracute and Acute Forms

The peracute form of fowl cholera in chickens is characterized by sudden death in apparently healthy birds with minimal or absent premonitory signs [1]. Mortality escalates rapidly, with multiple deaths occurring within a 24- to 48-hour window [2]. In the acute form, affected chickens exhibit profound depression, anorexia, pyrexia (body temperature elevated to 43.5 to 44.5 degrees Celsius), ruffled feathers, mucoid to blood-tinged oral discharge, and cyanosis of the comb and wattles [3].

Respiratory signs including dyspnea, open-mouth breathing, and tracheal rales are commonly reported [1]. Diarrhea, initially watery and subsequently hemorrhagic, soils the vent feathers and surrounding plumage [2]. Mortality peaks within 3 to 7 days of outbreak onset, with untreated case fatality rates approaching 50 percent in susceptible layer flocks [3].

Chronic Form

Chronic fowl cholera develops in birds that survive the acute phase or in flocks with partial immunity derived from prior exposure or vaccination [1]. This form is characterized by localized suppurative and fibrinous infections involving the wattles (wattle edema or wattle necrosis), infraorbital sinuses (sinusitis with caseous exudate), conjunctiva (keratoconjunctivitis), synovial structures (arthritis and tenosynovitis), and foot pads (pododermatitis) [2]. Affected birds exhibit progressive emaciation, decreased egg production (drop of 20 to 40 percent), lameness, and unilateral or bilateral facial swelling [3].

Chronic infections can persist for weeks to months, with intermittent shedding of P. multocida in oronasal secretions and feces [1]. These carrier birds represent a major obstacle to disease eradication because they may appear clinically recovered while continuing to contaminate the environment and infect naive pennates [2].

Pathology and Pathogenesis

Gross Pathology

Necropsy of chickens succumbing to acute fowl cholera reveals characteristic lesions of profound septicemia [1]. Petechial and ecchymotic hemorrhages are distributed widely across the epicardium, serosal surfaces of the viscera, and subcutaneous tissues [2]. The liver is enlarged, friable, and bile-tinged, studded with multiple small, pale, necrotic foci measuring 1 to 2 millimeters in diameter that are pathognomonic for the disease [3].

Splenomegaly with a mottled appearance and capsular hemorrhages constitutes a consistent finding [1]. The lungs are congested and edematous, and the intestinal mucosa, particularly the duodenum, exhibits hyperemia, petechiation, and hemorrhagic enteritis [2]. In peracute cases, gross lesions may be minimal or entirely absent, with only generalized vascular congestion evident [3].

Histopathology

Histological examination of affected tissues reveals acute necrotizing inflammation with massive infiltration of heterophils and macrophages [1]. Hepatic lesions consist of discrete foci of coagulative necrosis surrounded by a zone of inflammatory cells (heterophils, macrophages, lymphocytes), with abundant intralesional gram-negative coccobacilli visible on tissue Gram stains [2]. Splenic parenchyma shows lymphoid depletion of the periarteriolar lymphoid sheaths, reticuloendothelial hyperplasia, and fibrinoid necrosis of arteriolar walls [3].

Pulmonary histopathology includes congestion, intra-alveolar edema, fibrin exudation, and heterophilic infiltration of the air capillaries and parabronchi [1]. In chronic wattle lesions, subcutaneous edema, fibrin deposition, and accumulation of necrotic cellular debris with a relatively sparse heterophilic infiltrate are observed [2].

Diagnosis

Clinical and Pathological Evaluation

Presumptive diagnosis of fowl cholera in chickens is based on an integrated assessment of clinical signs, flock mortality pattern, gross pathology, and histopathological findings [1]. An acute septicemic presentation with peracute mortality, cyanosis of the comb and wattles, and the characteristic hepatic necrotic foci and splenomegaly is highly suggestive [2]. However, definitive etiological diagnosis requires laboratory confirmation through bacterial isolation and molecular or serological identification [3].

Bacterial Culture and Isolation

Pasteurella multocida is isolated aseptically from liver, spleen, bone marrow, cardiac blood, or exudate from localized lesions collected at necropsy [1]. Samples are streaked onto 5 percent sheep blood agar or tryptic soy agar and incubated at 37 degrees Celsius under 5 to 10 percent carbon dioxide for 24 to 48 hours [2]. Colonies appear as small, grayish, translucent, nonhemolytic, mucoid colonies with a characteristic musty odor on blood agar [3].

Gram staining reveals gram-negative coccobacilli exhibiting bipolar staining [1]. The organism is positive for catalase, oxidase, and nitrate reduction, and ferments glucose, sucrose, and sorbitol without gas production [2]. Commercial biochemical test strips and automated bacterial identification systems provide species-level confirmation within 4 to 8 hours of obtaining a pure culture [3].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the species-specific KMT1 gene, which encodes an outer membrane protein, provide rapid, sensitive, and specific detection of P. multocida directly from clinical specimens without prior culture [1]. Multiplex PCR panels that differentiate P. multocida from other Pasteurellaceae species (e.g., Avibacterium paragallinarum, Gallibacterium anatis) are available and recommended for routine diagnostic use [2]. Real-time quantitative PCR (qPCR) enables quantification of bacterial DNA load in tissues and environmental samples and facilitates monitoring of treatment response and environmental contamination levels [3].

Serotyping and Molecular Epidemiology

Capsular typing is performed using multiplex PCR assays targeting serogroup-specific gene sequences: hyaD-hyaC for type A, bcbD for type B, dcbF for type D, ecbJ for type E, and fcbD for type F [1]. Somatic serotyping is accomplished by the Heddleston gel diffusion precipitin test using serotype-specific rabbit antisera or by LPS gene cluster PCR [2]. High-resolution strain discrimination for outbreak investigations and trace-back epidemiology is achieved through multilocus sequence typing (MLST) targeting seven housekeeping genes or whole-genome sequencing (WGS) with core genome MLST analysis [3].

Serological Testing

Enzyme-linked immunosorbent assays (ELISAs) employing purified capsular or LPS antigens are available for flock-level serosurveillance and vaccine response monitoring [1]. However, individual bird serodiagnosis is limited by variable antibody kinetics, potential cross-reactivity with other bacterial species (e.g., Mannheimia haemolytica), and the delayed appearance of measurable antibody titers relative to clinical onset [2]. A fourfold or greater rise in antibody titer between paired acute and convalescent sera collected 10 to 14 days apart provides supportive evidence of recent infection [3].

flowchart TD
    A[Clinical Presentation: Peracute mortality, cyanosis, dyspnea, hemorrhagic diarrhea], > B[Necropsy Findings: Hepatic necrotic foci, splenomegaly, petechial hemorrhages]
    B, > C[Sample Collection: Liver, spleen, bone marrow, cardiac blood, or wattle exudate]
    C, > D[Gram Stain: Gram-negative coccobacilli with bipolar staining]
    D, > E[Bacterial Culture: Blood agar, 5-10% CO2, 37 degrees C, 24-48 hours]
    E, > F[Biochemical Confirmation: Catalase positive, oxidase positive, glucose fermentation]
    F, > G[Species-Specific PCR: KMT1 gene amplification]
    G, > H[Capsular Typing: Multiplex PCR for serogroups A, B, D, E, F]
    G, > I[Somatic Serotyping: Heddleston gel diffusion or LPS gene PCR]
    H, > J[Molecular Epidemiology: MLST or WGS for strain typing and origin tracing]
    I, > J
    J, > K[Antimicrobial Susceptibility Testing: Broth microdilution or disk diffusion]
    K, > L[Therapeutic Decision and Control Strategy Implementation]

Treatment

Antimicrobial Therapy

Antimicrobial treatment of fowl cholera in chickens should be guided by in vitro susceptibility testing because resistance patterns vary geographically, temporally, and among serotypes [1]. Historically effective antimicrobial classes include tetracyclines, sulfonamides (potentiated with trimethoprim or ormetoprim), aminopenicillins, fluoroquinolones, and macrolides [2]. Chlortetracycline or oxytetracycline administered in the drinking water at 10 to 20 mg per kilogram body weight daily or incorporated into feed at 400 to 500 grams per ton for 7 to 14 consecutive days constitutes a standard treatment protocol [3].

Sulfadimethoxine (50 mg/kg) combined with ormetoprim (10 mg/kg) or trimethoprim (10 mg/kg) provides synergistic bactericidal activity and is administered via drinking water for 5 to 7 days [1]. Amoxicillin or ampicillin at 15 to 20 mg/kg intramuscularly or orally is effective against beta-lactamase-negative susceptible strains [2]. Fluoroquinolones such as enrofloxacin (10 mg/kg orally or intramuscularly for 5 days) and danofloxacin (5 mg/kg for 3 to 5 days) are highly effective but should be reserved for confirmed susceptibility and when regulatory approval permits, due to concerns about antimicrobial resistance selection and withdrawal period compliance [3].

Antimicrobial Resistance

Acquired resistance to tetracyclines, sulfonamides, and aminopenicillins has been documented in avian P. multocida isolates from multiple continents [1]. Resistance mechanisms include acquisition of plasmid-borne resistance genes (e.g., tet(H), tet(B), sul1, sul2), chromosomal point mutations in target genes (gyrA, parC for fluoroquinolones), and overexpression of efflux pumps [2]. Routine antimicrobial susceptibility testing by broth microdilution following Clinical and Laboratory Standards Institute (CLSI) guidelines or disk diffusion methods is strongly recommended to guide therapy and monitor regional resistance prevalence [3].

Supportive Care

Supportive measures during active outbreaks include provision of clean (hypochlorite-treated) drinking water, oral electrolyte solutions, and vitamin supplementation (vitamins A, D3, E, and C) to mitigate stress and support mucosal immunity [1]. Prompt removal and disposal of moribund and dead birds reduces environmental bacterial load and curtails fly-borne mechanical transmission [2]. Affected flocks should be monitored at least twice daily for clinical signs and mortality trends to evaluate therapeutic response and adjust protocols as needed [3].

Control and Prevention

Biosecurity

Rigorous biosecurity protocols are essential for preventing introduction and containing the spread of P. multocida in chicken flocks [1]. Core measures include controlled access to poultry houses with footbaths containing quaternary ammonium or phenolic disinfectants changed daily, dedicated footwear and coveralls for each house, and disinfection of vehicle tires and equipment entering the farm [2]. Rodent control programs using integrated pest management reduce mechanical vector risk, as rodents can transport P. multocida on their feet and fur [3].

All-in/all-out flock management with thorough cleaning and disinfection between cycles eliminates residual organic contamination [1]. Effective disinfectants against P. multocida include sodium hypochlorite (0.5 to 1.0 percent available chlorine), quaternary ammonium compounds (0.5 to 1.0 percent), and phenolic compounds (2.0 percent), applied at recommended contact times of 10 to 30 minutes after gross cleaning [2].

Vaccination

Vaccination is a cornerstone of fowl cholera control in endemic regions, especially for layer and breeder flocks [1]. Two principal vaccine types are available: inactivated bacterins and live attenuated vaccines [2]. Inactivated bacterins typically contain multiple formalin-killed P. multocida serotypes (commonly serotypes 1, 3, and 4) adjuvanted with aluminum hydroxide or oil emulsion. They are administered subcutaneously or intramuscularly in two doses 2 to 4 weeks apart, with booster vaccinations every 3 to 6 months [3].

Live attenuated vaccines derived from strain M9 (serogroup A, serotype 3) or the CU strain (serogroup B, serotype 2) are administered via drinking water (approximately 10^8 colony-forming units per bird) or by wing web stab [1]. These vaccines induce robust humoral (IgG, IgA) and cell-mediated immune responses and provide broader cross-serotype protection than bacterins [2]. However, live vaccines may cause transient localized reactions (wing web swelling, abscess formation) and are contraindicated in flocks with concurrent immunosuppressive disease or in those receiving immunosuppressive medications [3].

Autogenous vaccines prepared from farm-specific P. multocida isolates are employed when commercial vaccines fail to confer adequate protection due to serotype or strain mismatch [1]. The efficacy of autogenous bacterins depends on appropriate strain selection, reliable inactivation (formalin or binary ethylenimine), and optimal adjuvant formulation (aluminum hydroxide or water-in-oil emulsion) [2].

Flock Management

Management practices that reduce physiological stress and optimize flock health indirectly lower susceptibility to fowl cholera [1]. Key practices include maintaining recommended stocking densities (0.3 to 0.5 square meters per bird for layers), providing adequate ventilation (minimum 5 to 8 air changes per hour), delivering balanced nutrition (especially adequate vitamin A and selenium), and ensuring clean, uninterrupted water supply [2]. Newly introduced birds should be quarantined for a minimum of 30 days with clinical monitoring and, ideally, bacterial culture of tracheal swabs before integration into the established flock [3].

Regular monitoring of daily mortality (target less than 0.1 percent per day), egg production curves, and clinical signs facilitates early outbreak detection [1]. Strategic culling of chronically infected carrier birds, identified by persistent wattle swelling or lameness, reduces the within-flock infectious reservoir [2].

Eradication

In regions or production systems with low disease prevalence, eradication of fowl cholera from infected flocks may be pursued through complete depopulation, followed by thorough cleaning, disinfection, and repopulation with P. multocida-free replacement stock [1]. This approach is most feasible for small flocks and nucleus breeder operations where replacement costs and genetic value justify the intervention [2]. Complete depopulation eliminates all potential carrier birds and definitively breaks the within-house transmission cycle [3].

Differential Diagnosis

Fowl cholera in chickens must be systematically differentiated from other acute septicemic and respiratory diseases of poultry [1]. Principal differential diagnoses include highly pathogenic avian influenza (HPAI), virulent Newcastle disease (VND), infectious coryza, fowl typhoid (Salmonella Gallinarum), pullorum disease (Salmonella Pullorum), and acute colibacillosis due to avian pathogenic Escherichia coli [2]. Each of these conditions shares overlapping clinical signs (cyanosis, respiratory distress, diarrhea) and gross lesions (hepatic and splenic necrosis, hemorrhages), necessitating laboratory confirmation [3].

HPAI and VND both cause acute mortality, comb and wattle cyanosis, and respiratory signs, but are distinguished by the presence of neurological signs (torticollis, paralysis) in some infected birds, pancreatic necrosis (HPAI), and by virus isolation, RT-PCR, or serology [1]. Infectious coryza, caused by Avibacterium paragallinarum, presents with facial edema, sinusitis, and conjunctivitis but typically lacks the high mortality, systemic involvement, and hepatic necrosis characteristic of acute fowl cholera [2].

Fowl typhoid and pullorum disease produce hepatosplenomegaly with necrotic foci, but are caused by specific Salmonella serovars (Gallinarum, Pullorum) and are differentiated by bacterial culture on selective media (e.g., brilliant green agar, MacConkey agar) and serotyping [3]. Colibacillosis may mimic fowl cholera in its septicemic form, but hepatic lesions in colibacillosis tend to be fibrinous and perihepatic rather than discrete necrotic foci, and bacterial culture on MacConkey agar (on which E. coli appears as lactose-fermenting pink colonies) provides clear differentiation [1].

Conclusion

Fowl cholera in chickens remains a major cause of economic loss in commercial poultry production worldwide, with acute outbreaks incurring mortality rates of 20 to 80 percent and persistent chronic infections impairing productivity. Successful management requires an integrated understanding of Pasteurella multocida virulence mechanisms, transmission dynamics, and host-pathogen interactions at the molecular and cellular level. Evidence-based control programs combining strict biosecurity, strategic vaccination with appropriate serotype coverage, antimicrobial stewardship guided by routine susceptibility testing, and optimized flock management provide the most effective framework for disease prevention, outbreak containment, and long-term reduction of disease prevalence in endemic regions.

References

[1] D.E. Swayne, Ed., Diseases of Poultry, 14th ed. Hoboken, NJ: Wiley-Blackwell, 2020.

[2] Merck Veterinary Manual, 11th ed. Kenilworth, NJ: Merck and Co., 2021.

[3] P.J. Quinn, B.K. Markey, F.C. Leonard, E.S. Fitzpatrick, and S. Fanning, Veterinary Microbiology and Microbial Disease, 3rd ed. Oxford, UK: Wiley-Blackwell, 2019. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.